POSTER PRESENTATION INSTRUCTIONS POSTER Viewing: Location: Thursday, April 16 and Friday, April 17 Coles Ballroom (PEI Convention Centre) Viewing Times Thursday April 16: • Morning break 11:00 am to 12:30 pm o STUDENT POSTER PRESENTERS (SP) MUST BE AT THEIR POSTERS TO ANSWERS QUESTIONS! • Lunch between 12:30 pm to 1:00 pm • Welcome Reception 6:30 pm to 8:30 pm Viewing Times Friday April 17: • Morning break 11:00 am to 12:30 pm o POSTER PRESENTERS (P) MUST BE AT THEIR POSTERS TO ANSWERS QUESTIONS! • Lunch between 12:30 pm to 1:00 pm Poster Set-Up Time: • Wednesday April 15 between 4:00 pm – 6:00 pm • Thursday April 16 between 7:00 am – 10:00 am Poster Removal Time: • Friday April 17 at 1:00 pm * Should you require assistance onsite, please go to the Registration Desk. GENERAL INFORMATION • Poster Boards are 4ft high x 8ft wide. • A good poster size is 3ft high x 6ft wide. • Velcro (male side) and pin friendly. All presenting authors MUST be registered for the annual conference, no later than Monday March 2, 2015. If registration is not complete by this date, the abstract will be REMOVED and will NOT be published. STUDENT POSTER Presenters must fill in and submit to ([email protected]) a Student/Technologist/Trainee Awards Competition Form by Monday March 2, 2015. http://ammi.ca/media/75949/Student-Technologist-Trainee%20Award%20Form%20-%20EN%20v2.pdf HOTEL AND CONFERENCE REGISTRATION INFORMATION The host hotel for the conference is the Delta Prince Edward. Registration is also available at the Holman Grand Hotel. The room block release date is Monday, March 9, 2015. To register at Delta Prince Edward ($179.00 per night + taxes): https://www.deltahotels.com/Groups/Delta-Prince-Edward-Groups/AMMI-Canada-CACMID-Annual-Conference-2015 To register at the Holman Grand Hotel ($189.00 per night + taxes): https://bookings.ihotelier.com/The-Holman-GrandHotel/bookings.jsp?hotelId=75665&GroupID=1284095 Early Bird conference registration cut off is March 2, 2015! Register now and receive a $100.00 off your full conference registration. Just fill in your reservation number during the registration process. Offer valid while rooms are available. Register now: http://ammi.emsreg.com/ammi15/public/splash1.aspx Serial No. Prog. No. 0003 SP01 0004 SP02 0007 SP03 0021 SP04 0026 SP05 0028 SP06 0031 SP07 0035 SP08 0036 SP09 0040 SP10 0045 SP11 0046 SP12 0047 SP13 0048 SP14 0049 SP15 0051 SP16 0052 SP17 0056 SP18 0058 SP19 0060 SP20 STUDENT POSTER PRESENTATION ASSIGNMENT LIST Initial Last name Title B. GHADAKI COPD Symptom and Disease Screening in an HIV Population H. MIHIRETIE Intestinal Parasitosis in Relation to CD4+T Cells Levels and Anemia among HAART Initiated and Non-HAART Initiated Pediatric HIV Patients in Zewditu Memorial Hospital, Addis Ababa, Ethiopia G. CHAN Characterization of Canadian Hospital Infection Control Practices for Caregivers and Visitors C. LATA Antimicrobial Prescribing Practices in the Treatment of Suspected UTI in the Elderly in the Emergency Department: a Retrospective Single Centre Study H.Y. ZHOU The Infectiousness and/or Virulence of Isoniazid-Resistant vs. Susceptible Pulmonary Tuberculosis: A Case-Control Study in Alberta R. FATTOUH Meropenem MIC Profile of Carbapenemase Producing Enterobacteriaceae in a Low Prevalence Region N. RAJAPAKSE Creation of A Novel Pediatric Antimicrobial Stewardship Advanced Fellowship Training Program R. PRIYANTHA Emerging Antimicrobial Resistance among Staphylococcus Pseudintermedius, a Potential Zoonoses of Canine Origin A. BAI Positive Impact of Infectious Disease Consultation on Quality of Care, Mortality and Length of Stay in Staphylococcus aureus Bacteremia: Results from a Large Multicenter Cohort Study C. PENNEY Prospective Observational Study of Diagnosis of Urinary Tract Infection and Response to Therapy in Long Term Care J. CHONG Molecular Epidemiology of Vancomycin Heteroresistant CoagulaseNegative Staphylococci in a Neonatal Intensive Care Unit in Quebec S. LOTHER Increasing Incidence of Group C and Group G Streptococcal Bacteremia Attributed to Increased Bacterial Virulence Factors and Poor Outcomes M. ROSTOM Antimicrobial Stewardship in Primary Care: An Evaluation of the Management of Acute Uncomplicated Cystitis in a Family Health Team B. BURSTEIN Emergency Department Utilization of Respiratory Virus Testing for Febrile Young Infants Under Six Weeks of Age M. ALGHOUNAIM Clostridium difficile Infections (CDI) in Children: Are we overestimating rates just because of the diagnostic method used? S. FATHIMA Surveillance of Human Parainfluenza Types 1-4 and Association with Acute Lower Respiratory Tract Infections in Hospitalized Cases, Alberta, Canada (2010 – 2013) N. ZELYAS Clostridium difficile infection in solid organ transplant recipients at a tertiary care centre during 2006-2013 C. BOIKOS Safety of the Live-Attenuated Intranasal Influenza Virus (LAIV) Vaccine in Children and Adolescents with Cystic Fibrosis and their Healthy Siblings J. ZHANG Severe Skin Lesions Induced by a Predominant CA-MRSA Strain USA300 are Associated with a Unique Neutrophil Response and Involvement of Proteinase Activated Receptors (PARs) É. FORTIN Surveillance of Antimicrobial Use in Québec Acute Care Hospitals: A Revised February 24, 2015 Page 2 of 6 Serial No. Prog. No. Initial Last name 0065 SP21 K. POPIEL 0066 SP22 D. WHELLAMS 0068 SP23 G SHUMILAK 0073 SP24 Y. CHEN 0077 SP25 C. LE 0078 SP26 L. GOODLIFFE 0080 SP27 D.R. MACFADDEN 0082 SP28 L. RYAN 0084 SP29 A. DENISUIK 0085 SP30 S. 0086 SP31 0089 SP32 Y. S. DE L’ÉTOILEMOREL EMOND SURESH 0090 SP33 S. MASUD 0091 SP34 E. KOECK 0092 SP35 A. MCFARLANE 0094 SP36 G. POMERANZ 0098 SP37 D. HARRIS 0100 SP38 0101 SP39 E. A. VALLIERES DELORME 0103 SP40 H. AL SIDAIRI 0150 SP41 C. MARTINEZ DE LA PENA Title Dream or Almost Reality? Usefulness of Fecal Calprotectin and Serum Procalcitonin in Predicting a Positive C. difficile Toxin Gene Polymerase Chain Reaction Assay Successful use of intrathecal colistin in a case of Pseudomonas aeruginosa ventriculitis: a case report and brief review of the literature Prevalence of Anemia in the Saskatchewan Population with HIV Infection Rapid Identification of Bacteria in Positive Blood Cultures Using Smudge Plate Preparation and MALDI-TOF MS System Assessment of the management of suspected urinary tract infections for identification of targeted antimicrobial stewardship interventions Clinical Features and Outcomes of Influenza Infection in Community Dwelling Older Adults Presenting to Six Urban Emergency Departments Engaging Infectious Diseases And Microbiology Residents in Improving the Value of Healthcare: Choosing Wisely Incidence and Outcomes of Hospital-acquired C. difficile Infection at a Large Community Hospital Before and After a Multipronged Prevention and Management Initiative The Continued Rise of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Canadian Hospitals: CANWARD 2007-2013 Inpatient Care of Community Acquired Pneumonia: Opportunities for Improvement Feasibility of UV-C light disinfection in a Canadian hospital. Non-Polio Enterovirus Types Associated with Acute Flaccid Paralysis – A Systematic Review Evaluation of Matrix Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) for Yeast Identification Xpert MTB/RIF as a Supplemental Test to Acid-Fast Bacilli Sputum Microscopy in the Diagnosis of Tuberculosis: Potential Resource Savings Hospitalized Influenza Patients during 2013-2014; a Comparison of ICU and Ward Treated Patients including Antimicrobial Therapy, Adverse Events, and Outcomes Clinical Spectrum of Rhinovirus Infections in Hospitalized Children in Israel - a single center's experience Prosthetic Joint Infections: Patterns of Practice for Diagnosis, Management, and Outcome Urinary Biomarkers in Patients with Cystic Fibrosis Carbon Source Modulates Paradoxical Growth Effect of Caspofungin in Candida albicans Cost-effectiveness of MALDI- TOF MS in Clinical Analysis of Urine Specimens in Nova Scotia Role of Type IV Pili in the Clostridium difficile Pathogenic Program Revised February 24, 2015 Page 3 of 6 Serial No. Prog. No. 0121 SP42 Initial Last name B. BERENGER 0125 SP43 A. MA 0127 SP44 D. JEONG 0131 SP45 A. LAWANDI 0137 SP46 C. LAM 0139 SP47 A. CAMPIGOTTO 0144 SP48 G. SHAH 0145 SP49 W.J. CONNORS Title Detection and Characterization of a 2014 Escherichia coli O157:H7 Outbreak in Alberta by Multiple Molecular Methods Including Whole Genome Sequencing Heat Resistant Shiga Toxin-Producing Escherichia coli (STEC) from Clinical Cases in Alberta The Use of Antibiotics in the Treatment of Skin and Soft Tissue Infections in Selected First Nations Communities The Role of Inter-Hospital Sample Transport in Total Assay Time for Microbiological Screening Tests Investigation of Matrix Assisted Laser Desorption/Ionisation Time-ofFlight Mass Spectrometry (MALDI-TOF-MS) for detection of Clostridium difficile toxin A and B from stool samples Cumulative antimicrobial susceptibility data from ICUs at one institution: should data be combined? Infectious Complications After Central Venous Catheter Repair in Pediatric Patients Acute Odontogenic Infection Management in the OPAT Clinic Setting: a Quality Improvement Study in Calgary, Alberta Revised February 24, 2015 Page 4 of 6 Serial No. Prog. No. 0005 P01 0006 P02 0011 P03 0015 P04 0017 P05 0022 P06 0029 P07 0033 P08 0037 P09 0039 P10 0041 P11 0043 P12 0044 P13 0053 P14 0054 P15 0055 P16 0118 P17 0149 P18 0072 P19 0097 P20 POSTER PRESENTATION ASSIGNMENT LIST Initial Last name Title N. AL MUSAYEIB Antiprotozoal potential of phenolic compounds from Kleinia odora A. SHEPHARD In-vitro Antiviral Action of Amylmetacresol (AMC) and 2,4Dichlorobenzyl Alcohol (BCDA) Against the Respiratory Pathogen Parainfluenza Type 3 B.M. WILLEY Use of Temocillin Resistance (TemR) as a Phenotypic Diffusion Marker for Class D Carbapenemases (Carb) in Carbapenemase-Producing Organisms (CPO) N.L. GILBERT Seroconversion for Cytomegalovirus Infection in a Cohort of Pregnant Women in Quebec, 2010-2013 M. VALAN ARASU Novel Isosteviol Isolated From Pittosporum tetraspermum Exhibited Antimicrobial, Antibiofilm And Anticancer Activities M. ABIDI CYP2C19*17 Genetic Polymorphism and Therapeutic Challenges in an Allogeneic Stem Cell Transplant Recipient with Invasive Pulmonary Aspergillosis C. LAVIGNE Nanoparticles to Target HIV Reservoirs M. MCCONNELL Increased Recovery and Detection of Pathogens Using Copan’s WASPLab™ Total Laboratory Automation (TLA) A. BAI Usefulness of previous methicillin-resistant Staphylococcus aureus screening results in guiding empiric therapy for S. aureus bacteremia N. IRFAN Inadequate Symptom Documentation of Urinary Tract Infection in the Medical Chart K. RANA All-Oral 12-Week Combination Treatment with Daclatasvir (DCV) and Sofosbuvir (SOF) in Patients Infected with HCV Genotype (GT) 3: ALLY-3 Phase 3 Study E.S. SWENSON All-oral, Fixed-dose Combination Therapy with Daclatasvir/Asunaprevir/BMS-791325 for Non-cirrhotic Patients with Chronic HCV Genotype 1 Infection: UNITY-1 Phase 3 SVR12 Results E.S. SWENSON All-oral Fixed-dose Combination Therapy with Daclatasvir/Asunaprevir/BMS-791325, ± Ribavirin, for Patients with Chronic HCV Genotype 1 Infection and Compensated Cirrhosis: UNITY-2 Phase 3 SVR12 Results H. Y. ZHOU Recurrent Micafungin-Resistant Candida glabrata Candidemia with Prolonged Micafungin Treatment for Multiple Intra-abdominal Abscesses: A Case Report M-K. LEE Active Environmental Surveillance of Lyme Disease in British Columbia (2013 and 2014) R. FATTOUH Investigating the Potential Role of Bacterial Infection in Granulomatosis with Polyangiitis (GPA) P. N. LEVETT Evaluation of antigen detection for confirmatory testing of hepatitis C virus infection P.N. LEVETT Recurrent Invasive Haemophilus influenzae Serotype a Infection in an Infant M. REHAN Optimizing the Diagnostic Yield of Joint Fluid/ Tissue Culture for the Hamilton Regional Laboratory Medicine Program J. LEBLANC Pushing the Limits of Chemistry Point-of-Care Testing for the Management of Patients under Investigation for Ebola Virus Disease Revised February 24, 2015 Page 5 of 6 Serial No. Prog. No. 0099 P21 Initial Last name M. KISSOON 0109 P22 T. MAZZULLI 0114 P23 K. SAVAGE 0062 P24 X-F. ZENG 0122 P25 S. WEST 0134 P26 V. 0135 P27 0146 P28 0018 P29 J. M. L. K. MEIERSTEPHENSON KETTNER GRAHAM KADKHODA 0107 P30 R. ADWAN Title Increase in Methicillin-susceptible Staphylococcus aureus with Reduced Susceptibility to Triclosan Over the Last 20 Years Characterizing the resistance related mutations in the NS3 protease of Hepatitis C-infected Ontario patients. Iron Restriction to Clinical Isolates of Candida albicans by DIBI Inhibits Growth and Increases Sensitivity to Azole Antifungals Deletion of DprA RF Domain Attenuates the Virulence of Streptococcus pneumonia SNAP—Sepsis Now a Priority: Development and Implementation of a Sepsis Algorithm in the Emergency Department of an Academic Hospital What a Fluke: A Case of Biliary Fascioliasis in a Recent Immigrant AMR, Public Health, and Knowledge Translation: A Forward Approach Oversight of Human and Animal Pathogens and Toxins The Retrospective Study of the Prevalence and Clinical Significance of Hepatitis B Virus Precore and Basal Core Promoter Variants Mycoplasma pneumoniae Infection in Children Less Than Five Years of Age; a 17 Years Review Revised February 24, 2015 Page 6 of 6